加載中........
×

MedSci 2020年期刊智能查詢系統(2019年度)

期刊關鍵詞: 支持模糊智能搜索,多關鍵詞組合

期刊領域: 可留空

IF范圍: 小于 大于 填數字,填寫自己想選擇的雜志影響因子范圍,可留空

排列方式: 文章數量往往與發表的周期有關

注冊會員 APP首發更新 在線咨詢

    以下是對 ELIFE 雜志介紹
    縮寫名/全名
    ISSN號 2050-084X
    被收錄情況 Science Citation Index Expanded
    BIOSIS Previews
    出版周期 Irregular
    H指數 115 (google發布,2017年度)
    CiteScore分區 所屬分類:Biochemistry, Genetics and Molecular Biology - General Biochemistry, Genetics and Molecular Biology 分區: 14/189|Neuroscience - General Neuroscience 分區: 9/111|Immunology and Microbiology - General Immunology and Microbiology 分區: 7/4
    CiteScore趨勢 6.99 (2018年度)
    APP下載
    相關報道 · eLife:體溫37℃,或在發低燒...研究發現人類體溫一直在下降
    · eLIfe:晚睡的你,為什么會抑制不住地想吃垃圾食品?
    · eLife:腦損傷激活膠質細胞產生神經元研究獲新進展
    · eLife:研究人員發現可能恢復受損聽覺細胞的蛋白質
    · eLife:再生牙根,或將成為可能
    · eLife:研究確定了健康子宮發育所需的細胞
    · eLife:阿爾茨海默癥的基因可能在20多歲時就表現出影響
    · eLife:但要適可而止,短時間手機屏幕光照不會影響睡眠
    · eLife:腸道微生物保護神經免受病毒感染傷害
    · elife:三大頂級醫學期刊隨機對照試驗分析:近400項研究結論被推翻,心血管疾病最常見
    出版社或管理機構雜志由  eLife Sciences Publications  出版或管理。    ISSN號:2050-084X
    雜志簡介/稿件收錄要求Aims & scope
    eLife publishes outstanding research in the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research. Our 32 Senior editors and 282-member Board of Reviewing Editors are among the most respected and accomplished individuals in their fields – from human genetics and neuroscience to biophysics and epidemiology. Where necessary, our Senior editors will also consult with external guest editors to evaluate new submissions.

    接收領域

    BIOCHEMISTRY
    BIOPHYSICS AND STRUCTURAL BIOLOGY
    CANCER BIOLOGY
    CELL BIOLOGY
    COMPUTATIONAL AND SYSTEMS BIOLOGY
    DEVELOPMENTAL BIOLOGY AND STEM CELLS
    ECOLOGY
    EPIDEMIOLOGY AND GLOBAL HEALTH
    GENES AND CHROMOSOMES
    GENOMICS AND EVOLUTIONARY BIOLOGY
    HUMAN BIOLOGY AND MEDICINE
    IMMUNOLOGY
    MICROBIOLOGY AND INFECTIOUS DISEASE
    NEUROSCIENCE
    PLANT BIOLOGY

    2015年數據:

    DAYS TO INITIAL DECISION ----4 days

    DAYS TO POST-REVIEW DECISION ---33 days

    DAYS SUBMISSION TO ACCEPTANCE----116 days

    At eLife, we’ve taken a fresh approach to peer review to save you time, and to provide clear direction and constructive input. Decisions are quick and efficient; revision requests are designed to be clear and manageable; and multiple rounds of revision are usually avoided. Here’s how it works:

    Initial decisions are delivered quickly

    Our Senior editors decide whether initial submissions are appropriate for in-depth peer review, usually in consultation with members of the Board of Reviewing Editors.

    Active scientists make all decisions

    A Senior editor assigns a member of the Board of Reviewing Editors to oversee the peer-review process. The Reviewing editor usually reviews the article him or herself, calling on one or two additional reviewers as needed.

    Revision requests are consolidated

    Reviewers get together online to discuss their recommendations, refining their feedback, and striving to provide clear and concise guidance. If the work needs essential revisions before it can be published, the Reviewing editor incorporates those requirements into a single set of instructions.

    Limited rounds of revision

    Additional rounds of revision are largely eliminated, as the Reviewing editor is able to assess most revised submissions without further outside review.

    Decisions and responses are available for all to read

    In the interests of openness and transparency we publish the most substantive parts of the decision letter after review and the associated author responses.




    雜志主頁/投稿鏈接ELIFE 主頁  (點擊9557次)  | 投稿鏈接(點擊3658次)
    常用鏈接

    免費全文(pubmed central) | 投稿經驗 | Medsci期刊指數 | 雜志主頁 | 投稿鏈接 |

    web對話
    500彩票网开奖结果